 07-01-01 Clinical trials with retinoids for breast cancer chemoprevention |
| 07-01-01 Epidermal growth factor receptor tyrosine kinase inhibitors and bone metastases: different mechanisms of action for a novel therapeutic appl |
| 07-01-01 Emerging anti-cancer molecular mechanisms of aminobisphosphonates |
| 07-01-01 TRPM8 in prostate cancer cells: a potential diagnostic and prognostic marker with a secretory function |
| 07-01-01 Activation of multiple cancer-associated genes at the ERBB2 amplicon in breast cancer |
| 06-09-10 The pleiotropic roles of transforming growth factor beta in homeostasis and carcinogenesis of endocrine organs |
| 06-09-10 The emerging roles of DNA methylation in the clinical management of prostate cancer |
| 06-09-10 Pathogenesis, diagnosis and management of thyroid nodules in children |
| 06-09-10 p53 and breast cancer, an update |
| 06-09-10 Insulin-like growth factor (IGF)-I, IGF binding protein-3, and breast cancer risk: eight years on |
| 06-09-10 Is oestrogen receptor- ? a predictor of endocrine therapy responsiveness in human breast cancer? |
| 06-09-10 Molecular links between obesity and breast cancer |
| 06-09-10 Future perspectives of selective estrogen receptor modulators used alone and in combination with DHEA |
| 06-09-10 Beyond peroxisome proliferator-activated receptor signaling: the multi-facets of the antitumor effect of thiazolidinediones |
| 06-09-10 Beyond peroxisome proliferator-activated receptor signaling: the multi-facets of the antitumor effect of thiazolidinediones |
